Header Logo

Connection

Mehmet Altintas to Mice

This is a "connection" page, showing publications Mehmet Altintas has written about Mice.
Connection Strength

0.841
  1. Reduction of proteinuria through podocyte alkalinization. J Biol Chem. 2014 Jun 20; 289(25):17454-67.
    View in: PubMed
    Score: 0.085
  2. Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis. 2012 Feb 07; 11:21.
    View in: PubMed
    Score: 0.073
  3. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis. 2011 Nov 03; 10:198.
    View in: PubMed
    Score: 0.071
  4. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res. 2011 Mar; 52(3):480-8.
    View in: PubMed
    Score: 0.067
  5. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
    View in: PubMed
    Score: 0.041
  6. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5. Kidney Int. 2023 06; 103(6):1056-1062.
    View in: PubMed
    Score: 0.039
  7. Simultaneous stabilization of actin cytoskeleton in multiple nephron-specific cells protects the kidney from diverse injury. Nat Commun. 2022 05 03; 13(1):2422.
    View in: PubMed
    Score: 0.037
  8. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis. EBioMedicine. 2021 Oct; 72:103617.
    View in: PubMed
    Score: 0.035
  9. Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
    View in: PubMed
    Score: 0.032
  10. Nonimmune cell-derived ICOS ligand functions as a renoprotective av?3 integrin-selective antagonist. J Clin Invest. 2019 04 01; 129(4):1713-1726.
    View in: PubMed
    Score: 0.030
  11. Single-nephron proteomes connect morphology and function in proteinuric kidney disease. Kidney Int. 2018 06; 93(6):1308-1319.
    View in: PubMed
    Score: 0.028
  12. TRPC5 Does Not Cause or Aggravate Glomerular Disease. J Am Soc Nephrol. 2018 02; 29(2):409-415.
    View in: PubMed
    Score: 0.027
  13. High-content screening assay-based discovery of paullones as novel podocyte-protective agents. Am J Physiol Renal Physiol. 2018 02 01; 314(2):F280-F292.
    View in: PubMed
    Score: 0.027
  14. A tripartite complex of suPAR, APOL1 risk variants and av?3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
    View in: PubMed
    Score: 0.026
  15. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
    View in: PubMed
    Score: 0.026
  16. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1. J Biol Chem. 2017 Jan 13; 292(2):732-747.
    View in: PubMed
    Score: 0.025
  17. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov; 26(11):2741-52.
    View in: PubMed
    Score: 0.023
  18. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29.
    View in: PubMed
    Score: 0.021
  19. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem. 2013 Dec 20; 288(51):36598-609.
    View in: PubMed
    Score: 0.020
  20. Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta. 2013 Jun; 1830(6):3696-710.
    View in: PubMed
    Score: 0.020
  21. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest. 2011 Oct; 121(10):3965-80.
    View in: PubMed
    Score: 0.018
  22. Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest. 2010 Nov; 120(11):4055-64.
    View in: PubMed
    Score: 0.017
  23. Establishment of protein delivery systems targeting podocytes. PLoS One. 2010 Jul 29; 5(7):e11837.
    View in: PubMed
    Score: 0.016
  24. Modification of kidney barrier function by the urokinase receptor. Nat Med. 2008 Jan; 14(1):55-63.
    View in: PubMed
    Score: 0.014
  25. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest. 2007 Aug; 117(8):2095-104.
    View in: PubMed
    Score: 0.013
  26. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol. 2007 Jan; 18(1):29-36.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.